KANAMYCIN/ANAFASIS 250MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
KANAMYCIN/ANAFASIS 250MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Authorised
- Kanamycin sulfate
Product identification
Medicine name:
KANAMYCIN/ANAFASIS 250MG/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
- Kanamycin sulfate
Target species:
-
Cat
-
Dog
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Kanamycin sulfate250.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Cat
-
Not applicableno withdrawal period
-
- Dog
-
Not applicableno withdrawal period
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01GB04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Uplab Pharmaceutical Company Ltd.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 30551/14/05-06-2015/K-0210401
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
